These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7521825)

  • 21. Quantitative structure-pharmacokinetics relationships and their importance in drug design, possibilities and limitations.
    Seydel JK
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):571-81. PubMed ID: 6513673
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety assessment of drug metabolites: Characterization of chemically stable metabolites.
    Humphreys WG; Unger SE
    Chem Res Toxicol; 2006 Dec; 19(12):1564-9. PubMed ID: 17173369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacological aspects of drug toxicity testing.
    Ackermann E
    Pol J Pharmacol Pharm; 1980; 32(2):237-41. PubMed ID: 7454628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The induction of microsomal cytochrome P-450 and its medical consequences].
    Pfeil D; Friedrich J
    Pharmazie; 1985 Apr; 40(4):217-21. PubMed ID: 3892550
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and toxicological significance of toxicity mechanisms].
    Gillmann H
    Arzneimittelforschung; 1977; 27(96):1819-20. PubMed ID: 579146
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical importance of pharmacokinetic and pharmacodynamic drug interactions.
    Koch-Weser J
    Neth J Med; 1977; 20(2):59-70. PubMed ID: 325426
    [No Abstract]   [Full Text] [Related]  

  • 27. [Protein malnutrition and drug metabolism].
    Yue TL
    Sheng Li Ke Xue Jin Zhan; 1987 Jul; 18(3):246-51. PubMed ID: 3118461
    [No Abstract]   [Full Text] [Related]  

  • 28. The gastrointestinal microbiota as a site for the biotransformation of drugs.
    Sousa T; Paterson R; Moore V; Carlsson A; Abrahamsson B; Basit AW
    Int J Pharm; 2008 Nov; 363(1-2):1-25. PubMed ID: 18682282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction: Human metabolites in safety testing (MIST) issue.
    Guengerich FP
    Chem Res Toxicol; 2009 Feb; 22(2):237-8. PubMed ID: 19216576
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of microsomes and nuclear envelope in the metabolic activation of benzo(a)pyrene leading to binding with nuclear macromolecules.
    Pezzuto JM; Lea MA; Yang CS
    Cancer Res; 1977 Sep; 37(9):3427-33. PubMed ID: 884686
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein-site targeting. Diversification of the drug discovery process.
    Krantz A
    Nat Biotechnol; 1998 Dec; 16(13):1294. PubMed ID: 9853592
    [No Abstract]   [Full Text] [Related]  

  • 32. An in vitro transcription assay for probing drug-DNA interactions during active transcription of DNA.
    Phillips DR; Crothers DM
    Methods Mol Biol; 1995; 37():89-105. PubMed ID: 7540091
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma and tissue binding considerations in drug disposition.
    Wilkinson GR
    Drug Metab Rev; 1983; 14(3):427-65. PubMed ID: 6347593
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonlinear pharmacokinetics relative to toxicity and use of toxicological data.
    Ramsey JC
    Drug Metab Rev; 1982; 13(5):779-97. PubMed ID: 6754308
    [No Abstract]   [Full Text] [Related]  

  • 35. Reductive drug metabolism.
    Mc Lane KE; Fisher J; Ramakrishnan K
    Drug Metab Rev; 1983; 14(4):741-99. PubMed ID: 6352224
    [No Abstract]   [Full Text] [Related]  

  • 36. Aging and the liver.
    Kitani K
    Prog Liver Dis; 1990; 9():603-23. PubMed ID: 2156317
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of stable isotopes in the elucidation of drug biotransformation processes.
    Vandenheuvel WJ
    Xenobiotica; 1987 Mar; 17(3):397-412. PubMed ID: 3554789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
    Baillie TA
    Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic perspectives on in vitro toxicity tests.
    Oesch F; Glatt H; Utesch D
    Xenobiotica; 1988 Jan; 18 Suppl 1():35-44. PubMed ID: 3125692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing drugs to avoid toxicity.
    Smith GF
    Prog Med Chem; 2011; 50():1-47. PubMed ID: 21315927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.